Are We Trying to Buy an Aesthetic?

I enjoy observing (and participating in) the modern culture of consumerism. I also enjoy writing about these observations – previously tackling the topic from the perspectives of sustainability and the culture surrounding it. Today, we will be contemplating whether we have subconsciously taken to ‘building our own brand’, by trying to neatly fit into designated aesthetics, whether these categories guide our choices more than they should and whether we are trying to buy our idea of a product, rather than the product itself.

Are We Trying to Buy an Aesthetic?

Diseases that Discriminate

Your immune system depends upon one key thing – the ability to differentiate between self and non-self material (which involves the detection of antigens – proteins on the surface of non-self cells), and when this ability fails, autoimmune disorders can occur; healthy body cells are attacked and damaged, leading to a range of symptoms and conditions from rheumatoid arthritis (which affects the joints) to psoriasis (which affects the skin). However, these disorders don’t occur indiscriminately – in fact, women are far more likely to have an autoimmune condition, and they make up around 80% of all patients diagnosed (with some variations depending on the condition).

Diseases that Discriminate

A Short History of the Kohinoor Diamond

Quite recently, campaigns, tweets and demands for the return of the exceptionally prestigious Kohinoor Diamond to India have become more vociferous. Housed in the Tower of London, the Kohinoor has mysterious origins, and a history that is still not fully known, but it is an integral part of the extension of political power and the symbolism of British colonialism. Since the death of Queen Elizabeth II, India, Iran, Afghanistan and Pakistan have all re-claimed their rights to the precious 105-carat diamond, sparking interest into its early past.

A Short History of the Kohinoor Diamond

Clinical Trials are Failing Women

A clinical trial allows researchers to compare the effects of different treatments, ensuring that drugs are safe and effective before being marketed. They are split into different phases which each test for specific things. If a medicine passes these phases, it can be giving a marketing licence, which makes it available on prescription, (though the side effects and effectiveness of the drug are still monitored while it is being used). In theory, these trials should be diverse, so that many different people can effectively benefit from the drug’s use, and for researchers to know how medicines affect these different groups of people. But clinical trials are still failing to sufficiently represent one of the largest groups on the planet: women.

Clinical Trials are Failing Women